CLINICAL VALUE OF CA125, CA153, HE4 JOINT DETECTION IN DIAGNOSIS OF GYNE-COLOGICAL MALIGNANCIES
10.3969/j.issn.1671-332X.2015.01.026
- VernacularTitle:CA125、CA153与 HE4联合检测在妇科恶性肿瘤诊断中的临床价值
- Author:
Shuhua XIE
;
Fangni KE
- Publication Type:Journal Article
- Keywords:
Gynecological malignancies;
CA125;
CA153;
HE4;
Joint detection
- From:
Modern Hospital
2015;(1):69-70,74
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical value of CA125, CA153, HE4 joint detection in diagnosis of gynecological malignancies.Methods 70 cases of gynecological malignancies were selected from our hospital in 2013, 72 cases of benign gynecological diseases selected in the same period, and 70 healthy controls were selected. The expression levels of CA125, CA153 and HE4 were detected and statistically analyzed.Results The positive rate of serum CA125 in the gynecological malignancies group was higher than that in the benign gynecological disease group (p <0.05).The positive rate of serum HE4 in the gynecological malignancies group was higher than that in the benign gynecological disease group (p <0.01).The positive rate of CA125, CA153, HE4 joint detection in the gy-necological malignancies group (up to 72.9%) was also significantly higher than that in the benign gynecological dis-ease group (p <0.01).Conclusion is a single tumor marker with the highest sensitivity and specificity for diagno-sis of gynecological malignancies.CA125, CA153, HE4 joint detection can improve the positive rate of diagnosis of gynecological malignancies.
